Meeting on the Mesa 2026 has ended. This guide stays up as the record of who was there. Next: Meeting on the Mesa 2027, Oct 18–20, 2027 in Phoenix

Cell and gene therapy companies at Meeting on the Mesa 2026

Oct 5–7, 2026 Phoenix, AZ ~1.5k attendees Website

140 cell and gene therapy companies are at Meeting on the Mesa 2026 — 91 presentations on the program. Most represented: Arbor Biotechnologies (1 on the program), Kyverna Therapeutics (1 on the program), REGENXBIO (1 on the program). 89 of them have their own page in this guide. As of Oct 6, 2026.

All 592 organizations at Meeting on the Mesa 2026 →

Focus area
Top represented
Showing 1–17 of 140 organizations
OrganizationMeeting on the Mesa 2026 Attendance
◇Silver Sponsor
Cell & gene therapySilver Sponsor
Develops gene-editing therapeutics for genetic diseases, including liver and central nervous system conditions and rare disorders.
Kyverna Therapeutics
Emeryville, CA
◇Silver Sponsor
Cell & gene therapySilver Sponsor
Develops CAR T-cell therapies for autoimmune diseases, including autologous and allogeneic products with rapid manufacturing processes.
Panel
Tue, Oct 6
1:30pm
REGENXBIO
Rockville, MD
◇Silver Sponsor
Cell & gene therapySilver Sponsor
Develops AAV gene therapies for retinal and rare diseases, including programs for wet AMD, diabetic retinopathy, Duchenne muscular dystrophy, and MPS II.
Spotlight
Mon, Oct 5
11:00am
◇Silver Sponsor
Cell & gene therapySilver Sponsor
Develops gene therapies for rare cardiovascular diseases, with additional programs in hematology and immunology and proprietary AAV manufacturing capabilities.
Kenai Therapeutics
San Diego, CA
◇Silver Sponsor
Cell & gene therapySilver Sponsor
Develops off-the-shelf allogeneic neuron replacement and gene-modified cell therapies for Parkinson’s disease and other neurological conditions.
Tenaya Therapeutics
South San Francisco, CA
◇Silver Sponsor
Cell & gene therapySilver Sponsor
Develops gene therapies and regenerative cell treatments for rare genetic disorders and other heart diseases.
uniQure
Amsterdam, Netherlands
◇Silver Sponsor
Cell & gene therapySilver Sponsor
Develops one-time gene therapies for hemophilia, Huntington’s disease, epilepsy, Fabry disease, and other severe conditions.
Spotlight
Mon, Oct 5
3:15pm
Innovation Spotlight company presentation
Cabaletta Bio
Philadelphia, PA
◇Silver Sponsor
Cell & gene therapySilver Sponsor
Develops engineered T-cell therapies for autoimmune diseases.
Workshop
Tue, Oct 6
8:00am
Panel
Tue, Oct 6
1:30pm
Inside the Autoimmune Revolution
◇Silver Sponsor
Cell & gene therapySilver Sponsor
Develops programmed T-cell therapies for cancer and autoimmune diseases, with candidates targeting blood cancers, solid tumors and autoimmune conditions.
Panel
Tue, Oct 6
1:30pm
Inside the Autoimmune Revolution
◇Silver Sponsor
Cell & gene therapySilver Sponsor
Develops engineered cell therapies using pluripotent stem cells and genome editing for neurological, cardiac, and immune diseases.
Editas Medicine
Cambridge, MA
◇Silver Sponsor
Cell & gene therapySilver Sponsor
Develops CRISPR-based gene-editing medicines for genetic diseases.
Panel
Tue, Oct 6
11:15am
Platform Technologies Across Modalities
Iovance
San Carlos, CA
◇Silver Sponsor
Cell & gene therapySilver Sponsor
Develops tumor-infiltrating lymphocyte therapies for cancer, including Amtagvi, an approved cell therapy for advanced melanoma.
Workshop
Mon, Oct 5
8:00am
Miromatrix
Eden Prairie, MN
◆Diamond Sponsor
Cell & gene therapyDiamond Sponsor
Develops bioengineered, transplantable human organs using decellularized scaffolds and recellularization technology.
Chair
Wed, Oct 7
10:00am
Ocugen
Malvern, PA
◇Silver Sponsor
Cell & gene therapySilver Sponsor
Develops gene and cell therapies for inherited retinal diseases, blindness and other serious conditions.
Panel
Tue, Oct 6
2:15pm
Leadership Perspectives: Beyond the Breakthrough
Beam Therapeutics
Cambridge, MA
◇Silver Sponsor
Cell & gene therapySilver Sponsor
Develops base-editing medicines that precisely modify genes to treat serious diseases.
Sponsor
In the meeting’s sponsor directory, with no session on the public program
Solid Biosciences
Charlestown, MA
◇Silver Sponsor
Cell & gene therapySilver Sponsor
Develops genetic medicines for Duchenne muscular dystrophy and other serious diseases, including gene therapies and genetic medicines for cardiac conditions.
Sponsor
In the meeting’s sponsor directory, with no session on the public program
Cell & gene therapy
Develops off-the-shelf allogeneic natural killer cell therapies designed to deplete B cells in autoimmune diseases.
Spotlight
Tue, Oct 6
3:00pm
Innovation Spotlight company presentation
Chair
Tue, Oct 6
1:30pm
Inside the Autoimmune Revolution

Explore the full Meeting on the Mesa 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Phoenix. Leave your work email and we’ll be in touch.

Privacy

Download the full Meeting on the Mesa 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers from cell and gene therapy companies

Tell us what you sell and we’ll find the people at these cell and gene therapy companies most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse Meeting on the Mesa 2026 by

Not affiliated with or endorsed by the Alliance for Regenerative Medicine or the Cell & Gene Meeting on the Mesa. Submit a correction